Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	7/5/2001 1:28:28 PM
From: Henrik	Read Replies (1) of 52153

Progen - volume and price activity + announcements Progen (NAZDAQ:PGLAF - ASX:PGL) has seen some upwards price and volume activity both on Nasdaq and in Australia. Progen recently received Ethics Committee Approval for Phase II Trial of Anti-Cancer Drug in United States biz.yahoo.com Another recent announcement : >>US Patent Granted for Gene Encoding Heparanase Enzyme and Its Use<< biz.yahoo.com Are any of you biotech buffs in a position to 1) explain what this is all about and 2) do Progen have something special. or is this just a lot of hot air ? Progen's homesite : progen.com.au Thank you. Henrik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next